Directorio

Participants will take a study pill every day and receive chemotherapy infusions every 1 to 2 weeks. They will also have tumor biopsies, provide blood and urine samples, and undergo regular CT or MRI scans to monitor their cancer during the study.

We are doing this study to see if an experimental drug called RMC-6236 (the study drug) is a safe and effective option for treating colorectal or pancreatic cancer when it is combined with different chemotherapy drugs.